Neuberger Quoted in The Wall Street Journal About Impact of Stimulus Bill on Unemployment Benefits
31 March 2020
Of Counsel Mark Neuberger was quoted in The Wall Street Journal article, “Unemployment Questions Answered: Do You Qualify for Benefits? What’s a Furlough vs a Layoff?” about how the federal stimulus bill impacts unemployment benefits and other labor and employment issues. The article noted the distinction between layoffs and furloughs and how the distinctions impact unemployment insurance eligibility and even benefits.
According to Neuberger, both workers who have been furloughed and laid off are still eligible for unemployment insurance, though the amount of the benefit varies by state.
“The difference between furlough and layoff shouldn’t matter for unemployment because unemployment generally looks at each workweek and determines if I’m making money or not,” he said.
Employers who intend to keep paying health benefits usually furlough employees, he added.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”